These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
298 related items for PubMed ID: 22535601
21. A surrogate marker profile for PML/RAR alpha expressing acute promyelocytic leukemia and the association of immunophenotypic markers with morphologic and molecular subtypes. Paietta E, Goloubeva O, Neuberg D, Bennett JM, Gallagher R, Racevskis J, Dewald G, Wiernik PH, Tallman MS, Eastern Cooperative Oncology Group. Cytometry B Clin Cytom; 2004 May; 59(1):1-9. PubMed ID: 15108165 [Abstract] [Full Text] [Related]
22. Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia. Zeleznikova T, Stevulova L, Kovarikova A, Babusikova O. Neoplasma; 2007 May; 54(6):471-7. PubMed ID: 17949229 [Abstract] [Full Text] [Related]
23. The immunophenotype of acute promyelocytic leukemia (APL): an ECOG study. Paietta E, Andersen J, Gallagher R, Bennett J, Yunis J, Cassileth P, Rowe J, Wiernik PH. Leukemia; 1994 Jul; 8(7):1108-12. PubMed ID: 8035602 [Abstract] [Full Text] [Related]
24. Flow cytometry rapidly identifies all acute promyelocytic leukemias with high specificity independent of underlying cytogenetic abnormalities. Dong HY, Kung JX, Bhardwaj V, McGill J. Am J Clin Pathol; 2011 Jan; 135(1):76-84. PubMed ID: 21173127 [Abstract] [Full Text] [Related]
25. [Application of CD123 in detection of minimal residual disease in acute promyelocytic leukemia]. Wang YZ, Chang Y, Zhu HH, Qin YZ, Li JL, Fu JY, Li LD, Chen SS, Huang XJ, Lu DP, Liu YR. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Jun; 14(3):427-32. PubMed ID: 16800913 [Abstract] [Full Text] [Related]
33. Secondary near-tetraploidy with double der(15)t(15;17) in acute promyelocytic leukemia in relapse. Morita Y, Takahashi A, Yamamoto K, Miki T, Murakami N, Miura O. Cancer Genet Cytogenet; 2004 Mar 01; 149(2):131-6. PubMed ID: 15036889 [Abstract] [Full Text] [Related]
34. The triple-negative (CD34-/HLA-DR-/CD11b-) profile rapidly and specifically identifies an acute promyelocytic leukemia. Rahman K, Gupta R, Singh MK, Sarkar MK, Gupta A, Nityanand S. Int J Lab Hematol; 2018 Apr 01; 40(2):144-151. PubMed ID: 28984423 [Abstract] [Full Text] [Related]
36. Immunophenotype of adult and childhood acute promyelocytic leukaemia: correlation with morphology, type of PML gene breakpoint and clinical outcome. A cooperative Italian study on 196 cases. Guglielmi C, Martelli MP, Diverio D, Fenu S, Vegna ML, Cantù-Rajnoldi A, Biondi A, Cocito MG, Del Vecchio L, Tabilio A, Avvisati G, Basso G, Lo Coco F. Br J Haematol; 1998 Sep 01; 102(4):1035-41. PubMed ID: 9734655 [Abstract] [Full Text] [Related]
37. Morphology of acute promyelocytic leukemia with cytogenetic or molecular evidence for the diagnosis: characterization of additional microgranular variants. Neame PB, Soamboonsrup P, Leber B, Carter RF, Sunisloe L, Patterson W, Orzel A, Bates S, McBride JA. Am J Hematol; 1997 Nov 01; 56(3):131-42. PubMed ID: 9371524 [Abstract] [Full Text] [Related]
38. Characterization of CD34+, CD13+, CD33- cells, a rare subset of immature human hematopoietic cells. Gaipa G, Coustan-Smith E, Todisco E, Maglia O, Biondi A, Campana D. Haematologica; 2002 Apr 01; 87(4):347-56. PubMed ID: 11940478 [Abstract] [Full Text] [Related]
39. A hypogranular variant of acute promyelocytic leukaemia showing a heterogenic immunophenotype with CD34, CD2, HLA-DR positivity: a case report and review of the literature. Patteet L, Vermeulen K, Pieters K, Van Assche E, Vrelust I, Gaddiseur A, Berneman ZN, Van der Planken M. Acta Clin Belg; 2012 Apr 01; 67(1):34-8. PubMed ID: 22480037 [Abstract] [Full Text] [Related]